Icon

FARESTON (nda020497)- (EQ 60MG BASE)

TOREMIFENE CITRATE KYOWA KIRIN
EQ 60MG BASE
No No
2009-Sep-29 Expired
None None
None No
FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.
2 0 2
Total Other Developers 1
Drugs with Suitability No
EQ 60MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ****** *** *********** ******** ******** ****, *** ********* ****, *********, , ******* (***) ***
****** *** *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.